[go: up one dir, main page]

WO2000044389A3 - Procede de preparation de vesicules membranaires - Google Patents

Procede de preparation de vesicules membranaires Download PDF

Info

Publication number
WO2000044389A3
WO2000044389A3 PCT/FR2000/000105 FR0000105W WO0044389A3 WO 2000044389 A3 WO2000044389 A3 WO 2000044389A3 FR 0000105 W FR0000105 W FR 0000105W WO 0044389 A3 WO0044389 A3 WO 0044389A3
Authority
WO
WIPO (PCT)
Prior art keywords
membrane vesicles
vesicles
preparing membrane
preparing
concerns
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2000/000105
Other languages
English (en)
Other versions
WO2000044389A2 (fr
Inventor
Olivier Dhellin
Sebastian Amigorena
Philippe Rameau
Joel Crouzet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Institut Curie
AP Cells Inc
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Institut Curie
AP Cells Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM, Institut Curie, AP Cells Inc filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to HK02102905.8A priority Critical patent/HK1042647A1/zh
Priority to JP2000595691A priority patent/JP2002535665A/ja
Priority to CA002360752A priority patent/CA2360752A1/fr
Priority to US09/890,319 priority patent/US6899863B1/en
Priority to AU30561/00A priority patent/AU768322B2/en
Priority to EP00900609A priority patent/EP1143982A2/fr
Priority to EA200100819A priority patent/EA003235B1/ru
Priority to IL14369200A priority patent/IL143692A0/xx
Publication of WO2000044389A2 publication Critical patent/WO2000044389A2/fr
Publication of WO2000044389A3 publication Critical patent/WO2000044389A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/34—Size-selective separation, e.g. size-exclusion chromatography; Gel filtration; Permeation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361—Ion-exchange
    • B01D15/363—Anion-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J41/00—Anion exchange; Use of material as anion exchangers; Treatment of material for improving the anion exchange properties
    • B01J41/20—Anion exchangers for chromatographic processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne un procédé de préparation de vésicules membranaires à partir d'un échantillon biologique caractérisé en ce qu'il comprend au moins une étape de traitement de l'échantillon par chromatographie d'échange d'anions et/ou de perméation de gel. L'invention est utilisée pour la préparation de vésicules d'origines et de natures variées, notamment à partir de cellules présentatrices d'antigènes ou de cellules tumorales. L'invention concerne aussi les vésicules ainsi obtenues et leurs utilisations.
PCT/FR2000/000105 1999-01-27 2000-01-19 Procede de preparation de vesicules membranaires Ceased WO2000044389A2 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
HK02102905.8A HK1042647A1 (zh) 1999-01-27 2000-01-19 製備膜囊的方法
JP2000595691A JP2002535665A (ja) 1999-01-27 2000-01-19 膜小胞を調製するための方法
CA002360752A CA2360752A1 (fr) 1999-01-27 2000-01-19 Procede de preparation de vesicules membranaires
US09/890,319 US6899863B1 (en) 1999-01-27 2000-01-19 Method for preparing membrane vesicles
AU30561/00A AU768322B2 (en) 1999-01-27 2000-01-19 Method for preparing membrane vesicles
EP00900609A EP1143982A2 (fr) 1999-01-27 2000-01-19 Procede de preparation de vesicules membranaires
EA200100819A EA003235B1 (ru) 1999-01-27 2000-01-19 Способ получения мембранных пузырьков
IL14369200A IL143692A0 (en) 1999-01-27 2000-01-19 Methods for preparing membrane vesicles

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9900886A FR2788780B1 (fr) 1999-01-27 1999-01-27 Procede de preparation de vesicules membranaires
FR99/00886 1999-01-27

Publications (2)

Publication Number Publication Date
WO2000044389A2 WO2000044389A2 (fr) 2000-08-03
WO2000044389A3 true WO2000044389A3 (fr) 2000-11-16

Family

ID=9541269

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2000/000105 Ceased WO2000044389A2 (fr) 1999-01-27 2000-01-19 Procede de preparation de vesicules membranaires

Country Status (11)

Country Link
US (1) US6899863B1 (fr)
EP (1) EP1143982A2 (fr)
JP (1) JP2002535665A (fr)
CN (1) CN1355704A (fr)
AU (1) AU768322B2 (fr)
CA (1) CA2360752A1 (fr)
EA (1) EA003235B1 (fr)
FR (1) FR2788780B1 (fr)
HK (1) HK1042647A1 (fr)
IL (1) IL143692A0 (fr)
WO (1) WO2000044389A2 (fr)

Families Citing this family (115)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL160142A0 (en) 2001-08-17 2004-06-20 Anosys Inc Methods and compounds for the targeting of protein to exosomes
WO2005121369A2 (fr) * 2004-06-02 2005-12-22 Sourcepharm, Inc. Microvesicules contenant de l'arn et methodes associees
US8021847B2 (en) 2004-06-02 2011-09-20 Proxy Life Science Holdings, Inc. Microvesicle-based compositions and methods
WO2007127848A1 (fr) * 2006-04-26 2007-11-08 University Of Louisville Research Foundation, Inc Isolation de vésicules membranaires de fluides biologiques et procédés d'utilisation
JP2010516786A (ja) * 2007-01-26 2010-05-20 ユニバーシティー オブ ルイヴィル リサーチ ファウンデーション，インコーポレーテッド ワクチンとしての使用のためのエキソソーム成分の改変
US9186405B2 (en) 2007-08-16 2015-11-17 The Royal Institution For The Advancement Of Learning/Mcgill University Tumor cell-derived microvesicles
US20100255514A1 (en) 2007-08-16 2010-10-07 The Royal Institution For The Advancement Of Learning/Mcgill University Tumor cell-derived microvesicles
KR101970908B1 (ko) 2008-02-01 2019-04-19 더 제너럴 하스피탈 코포레이션 의학적 질환 및 병태의 진단, 예후, 및 치료에 있어서 미세소포체의 용도
US20220162704A1 (en) * 2008-02-01 2022-05-26 The General Hospital Corporation Methods of preparing microvesicle micrornas from bodily fluids
US11266736B2 (en) 2008-04-17 2022-03-08 Vin De Bona Trading Company Pte Ltd Method of painting micro vesicles
US7897356B2 (en) * 2008-11-12 2011-03-01 Caris Life Sciences Methods and systems of using exosomes for determining phenotypes
CN102308004A (zh) 2008-10-30 2012-01-04 卡里斯生命科学卢森堡控股有限责任公司 评价rna图案的方法
SG2014014617A (en) 2009-07-16 2014-05-29 Gen Hospital Corp Nucleic acid analysis
WO2011031877A1 (fr) 2009-09-09 2011-03-17 The General Hospital Corporation Utilisation de microvésicules dans l'analyse de profils d'acide nucléique
WO2011031892A1 (fr) 2009-09-09 2011-03-17 The General Hospital Corporation Utilisation de microvésicules dans l'analyse de mutations kras
JP5892939B2 (ja) 2009-11-02 2016-03-23 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ 細胞状態をモニタリングするための方法及び間葉系幹細胞を不死化するための方法
AU2010324594B2 (en) 2009-11-30 2016-09-15 Caris Life Sciences Switzerland Holdings Gmbh Methods and systems for isolating, storing, and analyzing vesicles
US20120315324A1 (en) * 2010-02-05 2012-12-13 University Of Louisville Research Foundation, Inc. Exosomal compositions and methods for the treatment of disease
KR20130056855A (ko) 2010-03-01 2013-05-30 카리스 라이프 사이언스 룩셈부르크 홀딩스 치료진단용 생물학적 지표들
KR20130043104A (ko) 2010-04-06 2013-04-29 카리스 라이프 사이언스 룩셈부르크 홀딩스 질병용 순환 생물학적 지표들
WO2012006476A2 (fr) 2010-07-07 2012-01-12 Aethlon Medical, Inc. Procédés et compositions permettant de quantifier des exosomes
US20140045915A1 (en) 2010-08-31 2014-02-13 The General Hospital Corporation Cancer-related biological materials in microvesicles
EP2638057B1 (fr) 2010-11-10 2019-03-06 Exosome Diagnostics, Inc. Procédés d'isolement de particules contenant des acides nucléiques et extraction d'acides nucléiques à partir de celles-ci
SG190450A1 (en) * 2010-12-20 2013-06-28 Agency Science Tech & Res Method of purifying exosomes
EP3569607A1 (fr) 2011-05-11 2019-11-20 Exosome Diagnostics, Inc. Extraction d'acide nucléique à partir de matériaux biologiques hétérogènes
EP2723865B1 (fr) 2011-06-21 2019-03-27 Alnylam Pharmaceuticals, Inc. PROCÉDÉS DE DÉTERMINATION DE L'ACTIVITÉ DU RNAi CHEZ UN SUJET
GB201110777D0 (en) 2011-06-24 2011-08-10 Aqua Bio Technology Asa Methods and uses
GB201110783D0 (en) 2011-06-24 2011-08-10 Aqua Bio Technology Asa Methods and uses
ES2395793B1 (es) * 2011-07-28 2013-12-27 Consejo Superior De Investigaciones Científicas (Csic) Procedimiento de obtención y usos de vesículas de membrana de un organismo marino para su utilización industrial.
EP2748335B1 (fr) 2011-08-22 2018-10-03 Exosome Diagnostics, Inc. Marqueurs biologiques d'urine
EP2776587A4 (fr) 2011-11-10 2015-07-15 Exosome Diagnostics Inc Dosage du liquide céphalorachidien
WO2013079701A2 (fr) 2011-11-30 2013-06-06 University Of Bremen Expression d'arnmi dans le tissu placentaire
CN103479682B (zh) * 2012-06-14 2015-03-11 苏州恒宇生物科技有限公司 一种植物来源活性成分-纳米级膜性囊泡的制备方法
EP2875348B1 (fr) * 2012-07-19 2018-09-26 Atlantic Cancer Research Institute Procédé d'isolement de microvésicules
AU2013291761B2 (en) * 2012-07-19 2018-03-15 Reneuron Limited Stem cell microparticles
WO2014028763A1 (fr) 2012-08-15 2014-02-20 The University Of Chicago Produits thérapeutiques à base d'exosome contre des troubles neurodégénératifs
WO2014036391A1 (fr) 2012-08-30 2014-03-06 Exosome Diagnostics, Inc. Témoins pour dosages d'acide nucléique
WO2014055775A1 (fr) 2012-10-03 2014-04-10 Exosome Diagnostics, Inc. Utilisation de microvésicules dans le diagnostic, le pronostic et le traitement de maladies et d'états médicaux
US20150233800A1 (en) 2012-10-11 2015-08-20 Vin-De-Bona Trading Company Pte Ltd Method of painting microvesicles
US10942184B2 (en) 2012-10-23 2021-03-09 Caris Science, Inc. Aptamers and uses thereof
CN105026911B (zh) 2013-01-03 2019-01-22 外来体诊断公司 用于分离微囊泡的方法
EP2971282B1 (fr) 2013-03-14 2018-09-19 Pioma Inc. Histone h2ax microvésiculaire en tant que biomarqueur pour le stress génotoxique
EP2983721B2 (fr) * 2013-04-12 2021-01-20 Evox Therapeutics Limited Vésicules d'administration thérapeutiques
WO2014189842A2 (fr) 2013-05-21 2014-11-27 NX Pharmagen Utilisation de la ténascine-c comme marqueur extracellulaire de microparticules dérivées de tumeurs
JP2016526922A (ja) 2013-08-06 2016-09-08 エクソサム ダイアグノスティクス，インコーポレイティド 尿バイオマーカーコホート、遺伝子発現特性、およびその使用の方法
GB201317887D0 (en) 2013-10-09 2013-11-20 Reneuron Ltd Product
JP2016533752A (ja) 2013-08-28 2016-11-04 カリス ライフ サイエンシズ スウィッツァーランド ホー オリゴヌクレオチドプローブおよびその使用
EP3052616A4 (fr) * 2013-10-02 2017-03-29 Paradigm Biopharmaceuticals Limited Procédé de production d'exosomes
EP3061807B1 (fr) 2013-10-25 2019-03-06 Toppan Printing Co., Ltd. Dispositif de récupération de vésicule à membrane, procédé de récupération de vésicule à membrane et procédé d'analyse de vésicule à membrane
FR3014198B1 (fr) * 2013-12-03 2017-03-03 Biomerieux Sa Procede d'isolement d'exosomes
WO2015088288A1 (fr) * 2013-12-12 2015-06-18 사회복지법인 삼성생명공익재단 Procédé pour favoriser la génération d'exosome dérivé de cellule souche à l'aide de thrombine
EP3120857B1 (fr) 2014-03-18 2021-02-17 Samsung Life Public Welfare Foundation Compositions pour leur utilisation dans le traitement d'une maladie inflammatoire du cerveau comprenant des exosomes dérivés de cellules souches en tant que principe actif
EP3125907A4 (fr) 2014-04-01 2017-11-29 Cornell University Utilisation d'adn double brin dans des exosomes : un nouveau biomarqueur dans la détection du cancer
US11268085B2 (en) 2014-05-27 2022-03-08 Exosome Diagnostics, Inc. Methods for isolating microvesicles and extracting nucleic acids from biological samples
CA3084920C (fr) 2014-07-09 2023-02-28 Exosome Diagnostics, Inc. Procedes pour isoler des microvesicules et extraire des acides nucleiques a partir d'echantillons biologiques
WO2016011383A1 (fr) 2014-07-17 2016-01-21 The Trustees Of The University Of Pennsylvania Procédés permettant d'utiliser des exosomes pour surveiller l'état d'un organe transplanté
WO2016013660A1 (fr) 2014-07-24 2016-01-28 凸版印刷株式会社 Structure de membrane lipidique, support d'immobilisation de structure de membrane lipidique, et procédé de fusion de cellules
EP3112474A1 (fr) 2015-06-29 2017-01-04 Evonik Degussa GmbH Procédé de détection d'entérite nécrotique aviaire
WO2016145128A1 (fr) 2015-03-09 2016-09-15 Caris Science, Inc. Sondes oligonucléotidiques et utilisations de celles-ci
JP6967228B2 (ja) * 2015-06-12 2021-11-17 ハドソン インスティチュート オブ メディカル リサーチHudson Institute Of Medical Research 治療方法
WO2017004243A1 (fr) 2015-06-29 2017-01-05 Caris Science, Inc. Oligonucléotides thérapeutiques
EP3328873B1 (fr) 2015-07-28 2025-09-17 Caris Science, Inc. Oligonucléotides ciblés
EP3165926A1 (fr) 2015-11-06 2017-05-10 Humanitas Mirasole S.p.A. Procédé de caractérisation des microvésicules spécifiques de cellule
CN106811428A (zh) * 2015-11-30 2017-06-09 复旦大学 一种提取细菌外排膜囊泡的方法
RU2608509C1 (ru) * 2016-02-11 2017-01-18 Елена Сергеевна Кастарнова Способ получения экзосом из крови
US20190091307A1 (en) 2016-03-03 2019-03-28 Institut Gustave Roussy Ptps-based vaccines against cancer
WO2018057820A1 (fr) 2016-09-21 2018-03-29 Predicine, Inc. Systèmes et procédés de détection combinée d'altérations génétiques
KR20190020649A (ko) 2016-04-15 2019-03-04 엑소좀 디아그노스틱스, 인크. 역형성 림프종 키나아제(alk) 핵산 및 alk 융합 전사물의 혈장 기반 검출 및 암의 진단 및 치료에 있어 이의 용도
WO2017181161A1 (fr) 2016-04-15 2017-10-19 Predicine, Inc. Systèmes et procédés pour détecter des altérations génétiques
ES2908932T3 (es) 2016-05-05 2022-05-04 Exosome Diagnostics Inc Perfilado de ácidos nucleicos de microvesícula y usos del mismo como características distintivas en diagnóstico de rechazo de trasplante renal
AU2017263886B2 (en) 2016-05-13 2023-11-09 Exosome Diagnostics, Inc. Automated and manual methods for isolation of extracellular vesicles and co-isolation of cell-free DNA from biofluids
CN109153882B (zh) 2016-05-24 2022-03-04 公益财团法人癌研究会 细胞外小泡回收方法及细胞外小泡用容器
US11299733B2 (en) 2016-07-15 2022-04-12 University Of Massachusetts Process of delivering small RNAs to sperm
IL247368A0 (en) 2016-08-18 2016-11-30 Yeda Res & Dev Diagnostic and therapeutic uses of exosomes
CN110191962A (zh) 2016-10-21 2019-08-30 外来体诊断公司 外来体相关核酸的测序和分析
WO2018102162A1 (fr) 2016-11-30 2018-06-07 Exosome Diagnostics, Inc. Méthodes et compositions pour détecter des mutations dans du plasma à l'aide d'arn exosomal et d'adn acellulaire en provenance de patients atteints d'un cancer du poumon non à petites cellules
RU2748234C2 (ru) * 2016-12-23 2021-05-21 Эксофарм Лтд Способы и композиции для очистки или выделения микровезикул и экзосом
US20200149036A1 (en) 2017-01-02 2020-05-14 Exosome Diagnostics, Inc. Methods to distinguish rna and dna in a combined preparation
KR101875594B1 (ko) * 2017-01-13 2018-07-06 ㈜로제타엑소좀 금속을 이용한 세포밖 소포체의 분리 방법
CN110832089A (zh) 2017-05-12 2020-02-21 赢创运营有限公司 用于检测动物中由产气荚膜梭菌诱导的疾病的方法
US11891664B2 (en) 2017-05-17 2024-02-06 Exosome Diagnostics, Inc. Methods of detecting renal transplant rejection using microvesicle nucleic acid biomarkers
WO2019014486A1 (fr) 2017-07-12 2019-01-17 Exosome Diagnostics, Inc. Procédés d'isolement et d'enrichissement de populations de vésicules extracellulaires dérivées de biofluides, et procédés d'utilisation associés
EP3655531B1 (fr) 2017-07-18 2024-09-04 Exosome Diagnostics, Inc. Séquençage d'acides nucléiques associés à l'isolement exosomal chez des patients atteints de glioblastome multiforme
EP3660142A4 (fr) * 2017-07-26 2021-05-05 Rosetta Exosome Procédé d'isolement de vésicules extracellulaires à l'aide de cations
TR201716062A2 (tr) * 2017-10-18 2019-05-21 Tuerkiye Bilimsel Ve Teknolojik Arastirma Kurumu Tuebitak Bi̇r eksozomal terapöti̇k taşiyici üreti̇m yöntemi̇ ve bu yönteme uygun bi̇r şeki̇lde elde edi̇len bi̇r eksozomal terapöti̇k taşiyici
GB201717446D0 (en) 2017-10-24 2017-12-06 Evox Therapeutics Ltd Affinity purification of engineering extracellular vesicles
WO2019094578A1 (fr) 2017-11-09 2019-05-16 Alnylam Pharmaceuticals Inc. Dosages et procédés de détermination de l'expression du gène lect2
WO2019104169A1 (fr) * 2017-11-21 2019-05-31 Purina Animal Nutrition Llc Procédés de purification d'exosomes
WO2019160519A2 (fr) 2018-02-15 2019-08-22 Yeditepe Universitesi Procédé d'isolement d'exosomes par un système de fluide à deux phases
US12429465B2 (en) 2018-02-20 2025-09-30 Korea University Research And Business Foundation Multi-column for isolating exosomes and exosome isolation method
MX2020009044A (es) 2018-03-02 2020-10-12 Evonik Operations Gmbh Procedimiento in vitro para detectar disfuncion de la barrera intestinal en animales.
US12378608B2 (en) 2018-06-06 2025-08-05 Exosome Diagnostics, Inc. Methods for developing urine biomarkers and for detecting bladder cancer
GB201809622D0 (en) 2018-06-12 2018-07-25 Evox Therapeutics Ltd Engineering extracellular vesicles for affinity purification
BR112020026067A2 (pt) 2018-06-18 2021-03-23 Exopharm Limited métodos e composições para purificação ou isolamento de microvesículas e exossomas
CN108841777A (zh) * 2018-06-22 2018-11-20 北京恩泽康泰生物科技有限公司 基于静电吸附的胞外囊泡及其内含物的提取方法及装置
CN112805562A (zh) * 2018-07-31 2021-05-14 国立大学法人三重大学 外泌体的制造方法
US12258587B2 (en) 2018-11-20 2025-03-25 Exosome Diagnostics, Inc. Compositions and methods for internal controls of microvesicle isolations
US12449424B2 (en) 2018-12-14 2025-10-21 Evonik Operations Gmbh In vitro method for detecting avian intestinal dysbiosis
IT201800021226A1 (it) * 2018-12-27 2020-06-27 Supsi Scuola Univ Professionale Della Svizzera Italiana Processo e dispositivo per produrre esosomi
CN109856259A (zh) * 2018-12-29 2019-06-07 南通大学附属医院 一种血清胰腺癌外泌体特异蛋白及其再验证过程
KR102212465B1 (ko) * 2019-01-16 2021-02-03 서울시립대학교 산학협력단 알엔에이 나노입자 전달을 통한 소포체의 제조방법 및 이로부터 제조된 소포체
CN109825472A (zh) * 2019-03-01 2019-05-31 易春 一种细胞外囊泡的提取方法及试剂盒
JP7513869B2 (ja) * 2020-03-23 2024-07-10 澁谷工業株式会社 エクソソーム抽出装置およびエクソソームの抽出方法
WO2021209995A1 (fr) 2020-04-13 2021-10-21 Exoprother Medical Ltd. Vésicules dérivées de cellules comprenant une protéine p53 de type sauvage pour une thérapie antivirale
US20210322483A1 (en) 2020-04-16 2021-10-21 Ichilov Tech Ltd. Cell-derived particles presenting heterologous cd24 and use thereof in therapy
JP7706168B2 (ja) * 2020-06-12 2025-07-11 株式会社Egret・Lab 粒子を分級するための高吸水性ポリマー、及びそれを用いた分級方法
GB202010278D0 (en) 2020-07-03 2020-08-19 Evox Therapeutics Ltd Extracellular vesicles with improved half-life
IL277743A (en) 2020-10-01 2022-04-01 Yeda Res & Dev A method for diagnosing breast cancer
KR102679025B1 (ko) * 2020-12-30 2024-06-27 한국과학기술원 엑소좀 분리용 조성물 및 이를 이용한 엑소좀 분리 방법
GB202105925D0 (en) 2021-04-26 2021-06-09 Evox Therapeutics Ltd Modified extracellular vesicles (EVs) with improved half-life
JP2023104650A (ja) * 2022-01-18 2023-07-28 ダイセン・メンブレン・システムズ株式会社 細胞外小胞の分離精製方法
WO2024024336A1 (fr) * 2022-07-28 2024-02-01 株式会社ダイセル Dispositif de purification et de concentration d'un liquide comprenant une substance utile infime et procédé de production d'un liquide purifié et concentré d'une substance utile infime l'utilisant
CN117070450B (zh) * 2023-10-12 2024-01-16 哈药集团生物工程有限公司 一种外泌体的纯化方法
EP4537820A1 (fr) 2023-10-13 2025-04-16 Institut Gustave-Roussy Composé et combinaisons comprenant ledit composé pour améliorer une réponse immunitaire
EP4574155A1 (fr) 2023-12-22 2025-06-25 Christine Süßmuth Molécules destinées à être utilisées dans la régénération et le rajeunissement cellulaires

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997005900A1 (fr) * 1995-08-03 1997-02-20 Rijksuniversiteit Te Leiden Vesicules presentant des antigenes obtenues a partir de cellules
FR2766205A1 (fr) * 1997-07-16 1999-01-22 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE113468T1 (de) * 1987-07-29 1994-11-15 Liposome Co Inc Verfahren zur trennung von teilchen nach grösse.
US6165785A (en) * 1996-05-24 2000-12-26 University Of Cincinnati Bone marrow cultures for developing suppressor and stimulator cells for research and therapeutic applications
AU2710897A (en) * 1996-05-31 1998-01-05 Whitaker Corporation, The Rechargeable battery connector

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997005900A1 (fr) * 1995-08-03 1997-02-20 Rijksuniversiteit Te Leiden Vesicules presentant des antigenes obtenues a partir de cellules
FR2766205A1 (fr) * 1997-07-16 1999-01-22 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
WO1999003499A1 (fr) * 1997-07-16 1999-01-28 Institut National De La Sante Et De La Recherche Medicale Vesicule cellulaire denommee ''exosome'', leur preparation et utilisation dans la stimulation d'une reponse immunitaire

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
G. RAPOSO ET AL.: "B LYMPHOCYTES SECRETE ANTIGEN-PRESENTING VESICLES.", JOURNAL OF EXPERIMENTAL MEDICINE, vol. 183, March 1996 (1996-03-01), NEW YORK, N.Y., US, pages 1161 - 1172, XP002060486 *

Also Published As

Publication number Publication date
EA003235B1 (ru) 2003-02-27
WO2000044389A2 (fr) 2000-08-03
HK1042647A1 (zh) 2002-08-23
AU768322B2 (en) 2003-12-11
FR2788780B1 (fr) 2001-03-30
FR2788780A1 (fr) 2000-07-28
EP1143982A2 (fr) 2001-10-17
AU3056100A (en) 2000-08-18
EA200100819A1 (ru) 2001-12-24
CN1355704A (zh) 2002-06-26
JP2002535665A (ja) 2002-10-22
CA2360752A1 (fr) 2000-08-03
US6899863B1 (en) 2005-05-31
IL143692A0 (en) 2002-04-21

Similar Documents

Publication Publication Date Title
WO2000044389A3 (fr) Procede de preparation de vesicules membranaires
WO1998009990A8 (fr) Antigenes fongiques et processus de fabrication
EP0947142A3 (fr) Procédé de réticulation des protéines par des enzymes
AU3529299A (en) Method for immobilising and/or crystallising biological macromolecules on carbonnanotubes and uses
WO1994018316A3 (fr) Procedes et compositions de proteines d'edition de l'arn messager de l'apolipoproteine b
AU5794498A (en) Releasable nonvolatile mass-label molecules
FR2707522B1 (fr) Membrane de filtrage microporeuse soutenue, procédé de préparation de celle-ci, élément formant cartouche filtrante comprenant cette membrane et procédé de filtrage utilisant celle-ci.
AU2001226354A1 (en) Fixative system, method and composition for biological testing
WO2002055654A3 (fr) Technique d'immunosoustraction destinee a la preparation d'un echantillon pour electrophorese en gel en deux dimensions (2-dge)
EP1255209A3 (fr) Dispositif et méthode permettant une mise au point informatisée de protéines
ATE321535T1 (de) Mikropartikel mit adsorbenten oberflächen, verfahren zu ihrer herstellung und ihrer verwendung
AU2669897A (en) An improved method and system for performing banking transactions, including home banking
WO2001070197A3 (fr) Procede a cisaillement eleve/pression elevee pour la preparation de dispersions contenant des ingredients actifs au plan physiologique
NL194720B (nl) Werkwijze ter vervaardiging van een asymmetrisch membraan.
ATE307649T1 (de) Kontinuierliches verfahren zur trennung von stoffen nach molekülgrösse
WO2000020470A3 (fr) Dispersions aqueuses
WO1999020747A3 (fr) NOUVELLE KINASE HUMAINE POINT DE CONTROLE, hCDS1, COMPOSITIONS ET METHODES ASSOCIEES
WO2002037944A3 (fr) Systeme d'analyse de cellules par multiplexage
AU5066099A (en) Method for processing soybean by using enzyme, processed soybean thus obtained and foods containing the thus processed soybean
ZA975588B (en) Isolated nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof.
AU4943496A (en) Process and compounds for detection of analytes using remanence measurement, and use thereof
WO2000040757A3 (fr) Procede d'identification d'acides nucleiques
AU2002347859A1 (en) System, method, and apparatus for submitting genetic samples and receiving genetic testing results anonymously
WO1997039107A3 (fr) Procede permettant d'accelerer la maturation des cellules
WO1999039009A8 (fr) Procedes permettant d'isoler, d'amplifier et de caracteriser un adn

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 00802903.2

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 143692

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 30561/00

Country of ref document: AU

Ref document number: 2000900609

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2000 595691

Country of ref document: JP

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2360752

Country of ref document: CA

Ref document number: 2360752

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 09890319

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 200100819

Country of ref document: EA

WWP Wipo information: published in national office

Ref document number: 2000900609

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 30561/00

Country of ref document: AU

WWW Wipo information: withdrawn in national office

Ref document number: 2000900609

Country of ref document: EP